Researchers at National Taiwan University Hospital have developed a new diagnostic method for prostate cancer that significantly reduces the need for MRI scans and speeds up detection time. The new process can identify the cancer within one month, a substantial improvement over current methods. This breakthrough addresses the increasing incidence of prostate cancer in Taiwan’s aging population. The test focuses on identifying specific biomarkers, offering a less invasive and more efficient alternative to traditional diagnostic procedures. This advancement promises earlier intervention and potentially improved patient outcomes. The hospital anticipates this new method will become widely available, easing the burden on healthcare resources and benefiting patients across Taiwan. Further studies are underway to validate the findings and refine the diagnostic process.